About
Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi, and other protein expression platforms. He previously served as Senior Director of Business Development & Licensing at Ajinomoto Bio-Pharma Services, and held business development roles at Catalent, Lonza, BIOCRATES, and Los Alamos National Laboratory.
Invests in
Biotech
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Maggie Zhou
Associate Controller at Research Corporation Technologies